NYSE:SNN - Smith & Nephew Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$37.9099 -0.40 (-1.04 %)
(As of 02/21/2019 01:33 PM ET)
Previous Close$38.31
Today's Range$37.87 - $38.26
52-Week Range$32.22 - $40.78
Volume460,369 shs
Average Volume685,200 shs
Market Capitalization$16.58 billion
P/E Ratio18.77
Dividend Yield1.41%
Beta0.48
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery, various products, and technologies to assist in surgical treatment of the ear, nose, and throat; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-7401-7646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.90 billion
Cash Flow$3.0304 per share
Book Value$11.14 per share

Profitability

Miscellaneous

Employees15,933
Market Cap$16.58 billion
OptionableOptionable

Smith & Nephew (NYSE:SNN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a semiannual dividend on Friday, February 15th. Shareholders of record on Friday, April 5th will be given a dividend of $0.44 per share on Wednesday, May 8th. This represents a yield of 2.31%. The ex-dividend date is Thursday, April 4th. This is a positive change from Smith & Nephew's previous semiannual dividend of $0.25. View Smith & Nephew's Dividend History.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.59. View Smith & Nephew's Earnings History.

What guidance has Smith & Nephew issued on next quarter's earnings?

Smith & Nephew issued an update on its FY 2019 earnings guidance on Thursday, February, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.027-5.07564 billion.

What price target have analysts set for SNN?

7 analysts have issued twelve-month price objectives for Smith & Nephew's stock. Their predictions range from $42.00 to $42.00. On average, they anticipate Smith & Nephew's share price to reach $42.00 in the next year. This suggests a possible upside of 10.8% from the stock's current price. View Analyst Price Targets for Smith & Nephew.

What is the consensus analysts' recommendation for Smith & Nephew?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

News stories about SNN stock have trended somewhat positive on Thursday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Smith & Nephew earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term.

Who are some of Smith & Nephew's key competitors?

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Cambiar Investors LLC (1.29%), Iridian Asset Management LLC CT (0.62%), Bank of America Corp DE (0.33%), Foresters Investment Management Company Inc. (0.19%), Northern Trust Corp (0.16%) and Connor Clark & Lunn Investment Management Ltd. (0.15%).

Which institutional investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Dalton Greiner Hartman Maher & Co., Connor Clark & Lunn Investment Management Ltd., BlackRock Inc., Jarislowsky Fraser Ltd, Bank of America Corp DE, Bank of Montreal Can and Employees Retirement System of Texas.

Which institutional investors are buying Smith & Nephew stock?

SNN stock was purchased by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, D. E. Shaw & Co. Inc., Foresters Investment Management Company Inc., Boston Common Asset Management LLC, New York State Common Retirement Fund, Jane Street Group LLC, OLD Mission Capital LLC and Sivik Global Healthcare LLC.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $37.9099.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $16.58 billion and generates $4.90 billion in revenue each year. The medical equipment provider earns $663 million in net income (profit) each year or $2.02 on an earnings per share basis. Smith & Nephew employs 15,933 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is http://www.smith-nephew.com.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]


MarketBeat Community Rating for Smith & Nephew (NYSE SNN)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  316 (Vote Outperform)
Underperform Votes:  572 (Vote Underperform)
Total Votes:  888
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel